EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimizing cloxacillin prophylaxis in hip and knee arthroplasty based on population pharmacokinetics of unbound plasma concentrations

Gustaf Beijer, Katja Wallander iD, Bo Söderquist iD, Christian G Giske, Olof Breuer, Jaran Eriksen, Erik Eliasson

Journal of Antimicrobial Chemotherapy · 03.04.2026 · 81 (5)

DOI: 10.1093/jac/dkag116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 03.04.2026. Verfasst von Gustaf Beijer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Unit of Clinical Pharmacology, MDK, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Cloxacillin, Anti-Bacterial Agents, Antibiotic Prophylaxis, Arthroplasty, Replacement, Knee. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: grants from Region Stockholm, Vinnova/Platinea, Region Örebro County.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To characterize the population pharmacokinetics of unbound cloxacillin in patients undergoing total arthroplasty of the hip (THA) or knee (TKA), and to explore alternative dosing regimens for cloxacillin prophylaxis.

Methods

Plasma concentrations of total and unbound cloxacillin from 200 patients undergoing primary elective THA (n & 95) or TKA (n & 105) were analysed. Intravenous cloxacillin doses of 2 g were administered pre-surgery, and repeated after 2 and 6 hours. Samples (n & 496) were analysed using HPLC-MS/MS. Non-linear mixed-effects modelling was performed to develop a population pharmacokinetic model describing unbound cloxacillin exposure. Using this model, alternative prophylaxis regimens were explored with Monte Carlo simulations.

Results

A two-compartment model with non-linear protein binding adequately described the data. Estimated glomerular filtration rate (eGFR) and body weight (kg) were significant covariates on unbound cloxacillin clearance. In 13% of patients sampled at the end of surgery (n & 25/187), unbound cloxacillin <2 mg/L was observed. A model-predicted 18–22% (n & 36–43/200) of patients failed to sustain plasma levels ≥2 mg/L throughout the two-hour dosing interval with the current regimen. In contrast, a continuous 1 g/h infusion after a 1 g loading dose would ensure target attainment in >99% of patients, according to the model predictions.

Conclusions

For many THA and TKA patients, the current cloxacillin prophylaxis regimen may fail to provide adequate target site concentrations during the entire surgical procedure. Transitioning to a prolonged infusion protocol could increase attainment of PK/PD targets without exceeding the currently recommended total perioperative dose amounts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CloxacillinAnti-Bacterial AgentsAntibiotic ProphylaxisArthroplasty, Replacement, KneeArthroplasty, Replacement, HipPlasmaHumansFemaleAgedMaleMiddle AgedAged, 80 and overChromatography, High Pressure LiquidTandem Mass SpectrometryAdult

Substanzen

CloxacillinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Medical Unit of Clinical Pharmacology, MDK, Karolinska University Hospital, Stockholm, Sweden.
  • Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Infectious Diseases/Venhälsan, Södersjukhuset, Stockholm, Sweden.
  • Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
  • Department of Orthopedics, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

ORCID-Profile: Katja Wallander, Bo Söderquist

Förderung

  • grants from Region Stockholm
  • Vinnova/Platinea
  • Region Örebro County

Zitieren

APA

Beijer, G., Wallander, K., Söderquist, B., Giske, C. G., Breuer, O., Eriksen, J., & Eliasson, E. (2026). Optimizing cloxacillin prophylaxis in hip and knee arthroplasty based on population pharmacokinetics of unbound plasma concentrations. Journal of Antimicrobial Chemotherapy, 81(5). https://doi.org/10.1093/jac/dkag116

Vancouver

Beijer G, Wallander K, Söderquist B, Giske CG, Breuer O, Eriksen J, et al. Optimizing cloxacillin prophylaxis in hip and knee arthroplasty based on population pharmacokinetics of unbound plasma concentrations. Journal of Antimicrobial Chemotherapy. 2026;81(5). doi:10.1093/jac/dkag116

BibTeX
@article{Beijer2026,
  author = {Beijer, Gustaf and Wallander, Katja and Söderquist, Bo and Giske, Christian G and Breuer, Olof and Eriksen, Jaran and Eliasson, Erik},
  title = {Optimizing cloxacillin prophylaxis in hip and knee arthroplasty based on population pharmacokinetics of unbound plasma concentrations},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {5},
  doi = {10.1093/jac/dkag116}
}
Kostenlos starten →